A centre of expertise in muscle
- 10 December 2019 A phase 3 multicenter, prospective, open-label efficacy and safety study of IgIV in patients with Myasthenia gravis exacerbations
- 9 December 2019 Safety and treatment effects of nusinersen in longstanding adult 5q-SMA Type 3 - A prospective observational study
- 9 December 2019 Temporary reduction of membrane CD4 with the antioxidant MnTBAP is sufficient to prevent immune responses induced by gene transfer
- 6 December 2019 Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.
- 6 December 2019 MR fingerprinting for water T1 and fat fraction quantification in fat infiltrated skeletal muscles
- 3 December 2019 Abnormal coagulation parameters are a common non-neuromuscular feature in patients with SMA